UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000042421 |
|---|---|
| Receipt number | R000048424 |
| Scientific Title | Influence of coix seed on immune cells |
| Date of disclosure of the study information | 2020/11/11 |
| Last modified on | 2021/05/03 15:09:37 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Influence of coix seed on immune cells
Acronym
Influence of coix seed on immune cells
Scientific Title
Influence of coix seed on immune cells
Scientific Title:Acronym
Influence of coix seed on immune cells
Region
| Japan |
Condition
Condition
Healthy subject
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To assess the Influence of coix seed on immune cells.
Basic objectives2
Others
Basic objectives -Others
Influence
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Immune cells
Key secondary outcomes
Intestinal microbiota
Cytokines
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
No treatment
Stratification
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
NO
Concealment
No need to know
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Cooked coix seed, 160 g/day for 7 days.
Interventions/Control_2
None
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 65 | years-old | > |
Gender
Male
Key inclusion criteria
1. Aged 20 to 64 years old.
2. Subject who is in good physical condition to safely complete the study.
3. Subject who has received an explanation of the study in advance and is able to understand the content and agree with the purpose.
4. Subject who voluntarily participates with written consent
5. Subject who resides near Amano Clinic (1400-35, Oshikusa, Oshino, Minamitsuru, Yamanashi, Japan).
Key exclusion criteria
1. Subject with severe cardiovascular disorder, liver dysfunction, renal dysfunction, respiratory disorder, endocrine disorder, metabolic disorder, or history of these.
2. Subject with Hepatitis B or C, or history of these.
3. Subject who may cause allergies related to coix seed.
4. Subject whose blood drawn (such as blood donation) exceeding 200 mL within 1 month before the start of this study, or 400 mL within 3 months.
5. Subject with a body temperature of 37.5 degrees Celsius or higher within one week.
6. Subject who participated in another clinical trial within the past 3 months or who are currently participating in another clinical trial.
7. Subject who was judged by the principal investigator inappropriate to participate.
Target sample size
24
Research contact person
Name of lead principal investigator
| 1st name | Yoshio |
| Middle name | |
| Last name | Suzuki |
Organization
Juntendo University
Division name
Graduate School of Health and Sports Science
Zip code
2701695
Address
1-1, Hiragagakuendai, Inzai, Chiba
TEL
+81476981001
yssuzuki@juntendo.ac.jp
Public contact
Name of contact person
| 1st name | Yoshio |
| Middle name | Suzuki |
| Last name | Suzuki |
Organization
Juntendo University
Division name
Graduate School of Health and Sports Science
Zip code
2701695
Address
1-1, Hiragagakuendai, Inzai, Chiba
TEL
+81476981001
Homepage URL
yssuzuki@juntendo.ac.jp
Sponsor or person
Institute
Juntendo University, Graduate School of Health & Sports Science
Institute
Department
Personal name
Funding Source
Organization
The National Agriculture and Food Research Organization (NARO)
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics committee of Juntendo University Graduate School of Sports and Health Science
Address
1-1, Hiragagakuenndai, Inzai, Chiba
Tel
+81476981001
sc-kyomu@juntendo.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
あまの診療所（山梨県）
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 11 | Month | 11 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
19
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2020 | Year | 11 | Month | 10 | Day |
Date of IRB
| 2020 | Year | 11 | Month | 10 | Day |
Anticipated trial start date
| 2020 | Year | 11 | Month | 12 | Day |
Last follow-up date
| 2021 | Year | 01 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2020 | Year | 11 | Month | 11 | Day |
Last modified on
| 2021 | Year | 05 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048424
